CVS Health Q4 2020 Earnings Report
Key Takeaways
CVS Health's Q4 2020 results reflected COVID-19 impacts and related investments. Full year total revenues increased to $268.7 billion, up 4.6% compared to prior year. The company utilized its capabilities and community presence for COVID-19 testing and vaccine administration.
Full year total revenues increased to $268.7 billion, up 4.6% compared to prior year.
Full year and fourth quarter GAAP diluted earnings per share from continuing operations of $5.47 and $0.75
Full year and fourth quarter Adjusted EPS of $7.50 and $1.30
Generated full year cash flow from operations of $15.9 billion
CVS Health
CVS Health
CVS Health Revenue by Segment
Forward Guidance
The Company’s full year 2021 GAAP diluted EPS from continuing operations is projected to be in the range of $6.06 to $6.22, and full year 2021 Adjusted EPS is projected to be in the range of $7.39 to $7.55. The Company’s full year 2021 cash flow from operations is projected to be in the range of $12.0 billion to $12.5 billion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income